Incyte Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) Transcript
Good afternoon, everyone, and thank you for joining us for the Goldman Sachs CEO Unscripted Conference. We're really pleased to have Herve Hoppenot, Chairman, President and CEO of Incyte. Thank you, Herve, for joining us. Happy New Year.
Thank you for inviting me.
Questions & Answers
Thank you. And as we start or stand today -- as you stand today, sorry, with Jakafi, Pemazyre and Monjuvi and recently approved Opzelura and the current pipeline, what is your outlook on the overall business and where you must focus in 2022?
Salveen, thanks for the invitation. So 2022 is very simple. In fact, in many ways, it's about growth of revenue, and we have obviously Jakafi that is growing in its
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
